Abstract Aim To assess whether preoperative contrastenhanced magnetic resonance imaging (MRI) of the breast influences the rate of incomplete tumor excision. Methods In a cohort of 349 women with invasive breast cancer, patients eligible for breast-conserving therapy (BCT) on the basis of conventional imaging and palpation only (N = 176) were compared to those who had an additional preoperative MRI (N = 173). Multivariate analysis was applied to explore associations with incomplete tumor excision. Results MRI detected larger extent of breast cancer in 19 women (11.0%), leading to treatment change: mastectomy (8.7%) or wider excision (2.3%). Tumor excision was incomplete in 22/159 (13.8%) wide local excisions in the MRI group and in 35/180 (19.4%) in the non-MRI group (P = 0.17). Stratified to tumor type, incompletely excised infiltrating ductal carcinoma (IDC) was significantly associated with absence of MRI: 11/136 (8.1%) versus 2/126 (1.6%) (MRI present) (P = 0.02). No significant factors explained incomplete excision of other tumor types. Conclusion Preoperative MRI did not significantly affect the overall rate of incomplete tumor excision, but it yielded significantly lower rate of incompletely excised IDC. The reduction of incomplete excisions after MRI was smaller than the rate of a prior treatment change incurred by MRI.
Introduction
Breast-conserving therapy (BCT), consisting of wide local excision (WLE) of the tumor combined with postoperative radiotherapy, is the standard of care in loco-regional treatment of early (\3 cm) breast cancer. Large prospective randomized trials have demonstrated that the survival rates after BCT are equivalent to those obtained after radical mastectomy [1] [2] [3] . The 5-year local-recurrence rate after BCT is about 5% with survival rates of approximately 92% [2] [3] [4] [5] . The local-recurrence rate is, however, approximately twice as large in patients with incompletely excised tumors and in patients 40 years of age or younger [2] [3] [4] [5] . Results from major trials with long-term follow-up demonstrated that improvement of local control results in better survival, and complete gross excision of the primary tumor has been shown to maximize local control [2] [3] [4] [5] [6] .
To select the optimal therapeutic strategy, the size, growth pattern and location of the lesion must be accurately visualized. Conventional imaging by mammography and ultrasonography fails to accurately assess tumor extent in approximately one-third of patients eligible for BCT [7] . Several studies reported a higher sensitivity of contrastenhanced magnetic resonance imaging (CE MRI) to detect invasive breast cancer and to visualize disease extent compared to the standard workup using conventional imaging [8] [9] [10] [11] . These observations have led to changes in the surgical management of patients [12] [13] [14] [15] [16] [17] . Preoperative breast MRI for women with known breast cancer is, however, controversial due to the increase in cost, mastectomy rate and larger excisions, without knowing the benefit in local control [18] [19] [20] [21] [22] [23] . The therapy of most patients is not converted after preoperative MRI, but little is known whether the high sensitivity of CE MRI improves the precision of BCT in this group of patients.
The aim of this study was to assess whether preoperative MRI reduces the risk of an incomplete tumor excision, and to assess consequences in patient management.
Materials and methods

Patient cohort
All women with invasive breast cancer and eligible for BCT on the basis of conventional imaging and palpation presenting at our hospital between March 2002 and July 2004 were consecutively included. Women who underwent chemo-or hormone-therapy prior to surgery and women with only primary ductal carcinoma in situ (DCIS) were not included. Detection and staging of breast cancer was performed by mammography, ultrasonography, and physical examination. Ultrasonography was also used to detect pathological loco-regional lymph nodes [24] . Proof of breast cancer was obtained using fine-needle aspiration (FNA) or core biopsy. Treatment plans were established in consensus by a multi-disciplinary team of breast cancer specialists (radiologists, surgeons, medical oncologists, radiation oncologists, pathologists, and nurse practitioners).
In 2000, the MARGINS (Multi-modality Analysis and Radiogical Guidance IN breast conServing therapy) study started at our hospital. The aim of this single-institutional study was to investigate the use of conventional imaging in combination with MRI to improve the definition of the extent and localization of the tumor. In the MARGINS study, women with pathology-proven breast cancer and eligible for BCT were recruited for an additional preoperative breast MRI (the MRI group). The MRI results were discussed in a subsequent multi-disciplinary meeting at which time the initial treatment plan was confirmed or adjusted. In the current study, patients not recruited (the non-MRI group), either refused to participate, could not be imaged by MRI prior to the scheduled surgery date, or had contraindications for MRI, such as claustrophobia.
All data were obtained after written informed patient consent and approval of the institutional review board (the MRI group) or from established clinical guidelines and waiver of consent (the non-MRI group).
Prospective guidelines for management of additional findings at MRI Guidelines were established to handle additional findings detected at CE MRI, aiming to minimize treatment changes on benign findings [12] . In short, if additional findings were sufficiently close to the index lesion, BCT was pursued with larger wide-local excision margins to include the additional findings. Depending on the size of the breast, the total diameter of disease in patients eligible for BCT typically does not exceed 3 cm. If additional MRI findings were further away from the index lesion, attempts were made to obtain proof of malignancy by second-look targeted ultrasonography and FNA or biopsy. If pathology confirmed malignant disease over a region too large to allow cosmetically acceptable BCT, a conversion to mastectomy was advised. If pathology proof could not be obtained, BCT was advised and follow-up by MRI. The final treatment plan was implemented after consultation with the patient.
Magnetic resonance imaging
Magnetic resonance imaging was performed with a 1.5-tesla scanner (Magnetom, Siemens Medical Systems, Erlangen, Germany) using a coronal FLASH-3D technique. Both breasts were imaged in prone orientation, using a dedicated double-breast array coil. One series was acquired before the injection of contrast agent, and four series were acquired after intravenous injection of contrast agent (Prohance, Bracco-Byk Gulden, Konstanz, Germany); 0.1 mmol/kg body weight, at a rate of 2-4 ml/s. The series were acquired at intervals of approximately 120 s. The following MRI parameters were used: 3D coronal T1-weighted sequence, repetition time 8.1 ms, echo time 4.0 ms, isotropic voxels of 1.35 9 1.35 9 1.35 mm 3 and no fat suppression. Subtraction images were available to examine initial and late enhancement. Radiologists with experience in breast MRI read the examinations. If multiple lesions were visible, the total area including normal breast tissue between lesions, was indicated as the total disease extent.
Surgery
The surgical procedures were performed according to accepted surgical standards, with the aim to achieve tumorfree margins with the best possible cosmetic outcome [25, 26] . The procedures were carried out or directly supervised by fully trained surgeons specialized in breast surgery.
Results of preoperative diagnostic imaging were available in the operating theater. For non-palpable lesions, surgeons were typically guided by a gamma-ray detection probe, after preoperative intra-lesional injection of 99m Tc-nanocolloid (Nanocoll; GE-Healthcare, Eindhoven, The Netherlands) administered under ultrasound guidance [27] . Wide local excisions in our hospital are performed according to the technique described by Aspegren et al. [28] : the incision is typically radial, skin is removed only for cosmetic reasons, tumor resection is performed with an intended macroscopic margin of at least 1 cm, generally down to the fascia and reconstruction of the breast parenchyma is done by mobilization of breast tissue in order to minimize the cavity.
Pathology
At pathology, the excision specimens were handled according to a fixed protocol based on radiographic and pathological assessment, described by Egan [29] . Specimens were inked to indicate their orientation in the breast, sectioned into 5 mm parallel slices and radiographs were obtained. Cross sections of the tumor, surrounding breast tissue and nearest margins, as well as additional grossly or radiologically suspicious areas, were sampled for microscopic examination. Pathologists, experienced in breast pathology, assessed the specimens to report the largest diameter of invasive cancer, in situ components, growth pattern, margins, histological grade and type.
Grade was determined according to the Bloom and Richardson method resulting in well (grade 1), moderately (grade 2), or poorly (grade 3) differentiated carcinoma [30, 31] . An incomplete excision was defined as an excision that resulted in extension of the tumor into the edge of specimen. Incomplete excisions were rated as focally incomplete (tumor present in the resection margin in less than two low power fields) or extensively positive (tumor present in the resection margin in two or more low power fields).
Statistical analysis SPSS Version 15.0; SPSS Chicago, Ill, was used for all analyses. To explore the difference in patients and tumor characteristics between the MRI and the non-MRI group, Students t-tests were performed for normally distributed continuous variables, and Mann-Whitney-U and Fisher's exact test for the non-normally distributed variables.
Multivariate analysis using logistic regression (LR) was performed to determine which factors were significant explanatory variables for incomplete surgery. Backward LR based on step-wise feature selection (f-to-entry: 0.05, fto-remove: 0.10) was applied.
The following patient and tumor characteristics were fitted into the model to explore the association with incompletely excised tumor: age, palpable (yes/no), lymph node metastases (present/not present), tumor size, tumor histological grade (1, 2, 3) and MRI (done/not done). Subset analysis, using similar procedures, was performed for presence of various tumor types on the excision boundary (IDC, ILC and DCIS).
Results
Patient characteristics
At baseline the MRI group consisted of 173 women with 175 tumors (2 contra-lateral tumors prior to MRI). The non-MRI group consisted of 176 women with 180 breast tumors (4 contra-lateral tumors). The mean age was 56.1 years, standard deviation (SD) 9.9 years (range: 28-82) and 59.6 years, SD 11.1 years (range: 31-89) in the MRI group and non-MRI group, respectively (P = 0.02).
No significant differences were found between the tumor characteristics in the two groups: lymph node stage, palpability, tumor size, histological tumor type, and grade. The tumor type was invasive ductal carcinoma (IDC) in 274 (77.2%) of the cases. Invasive lobular carcinoma (ILC) was found in 53 (14.9%) of all cases. Patient characteristics are listed in Table 1 and Fig. 1 . The rate of patient inclusion in the MRI group and non-MRI group was comparable throughout the investigated study period.
Additional findings and patient management
In the MRI group, therapy was converted to mastectomy in 16/173 (9.2%) women after detection of additional pathology-proven disease (Table 1 ; Fig. 1 ). In 19 women (11.0%), tumor with a larger extent was found than anticipated using conventional imaging. Fifteen patients (8.7%) were advised a mastectomy because of larger tumor size (n = 3) and multi-focal disease spread, up to 9 cm (n = 12) ( Table 2) . In all cases, the spread of disease was confirmed by extensive histopathological examination of the specimens. In four cases (2.3%) a wider excision was performed than initially planned. Three women (1.7%) were found to have additional contra-lateral breast cancer, (not visible at conventional imaging). These MRI-detected contra-lateral tumors were not included in the current study. In one woman with a bilateral tumor the treatment was changed to bilateral mastectomy, according to the wish of the patient. The other two women underwent bilateral BCT. A total of 157 women with 159 tumors continued with wide-local excision.
In addition to malignant findings, 21 benign lesions in 175 breasts (12.0%) were detected at preoperative MRI. Three lesions were considered benign on the basis of ultrasound characteristics, four were proved to be benign after target ultrasound with fine-needle aspiration (FNA). Thirteen lesions were occult at target ultrasonography and considered benign by follow-up. The median follow-up time was 54.1 months (range: 37.0-70.1 months). The only therapy change for a benign lesion was a wider local excision than initially planned which included a fibroadenoma close to the index tumor.
Incomplete surgical excision
Surgical excision of the tumor was incomplete in 22 of the 159 procedures (13.8%) in the MRI group, and in 35 of the 180 procedures (19.4%) in the non-MRI group (P = 0.17). The types of disease at the margins of the incomplete excisions are shown in Table 3 . Incomplete excision of invasive disease was 8/159 (5%) and 19/180 (10.6%) in the MRI and in the non-MRI group, respectively, (P = 0.06). This difference was mainly caused by the lower rate of incompletely excised IDC in the MRI group: 2/126 (1.6%) versus 11/136 (8.1%), respectively, (P = 0.02). The mean weight of the excised specimens was 61.5 g (SD 35.0 g) in the MRI group and 65.0 g (SD 35.5 g) in the non-MRI group (P = 0.38).
Management after incomplete surgery
In the MRI group, 8/159 (5.0%) additional surgical procedures were performed after WLE. A re-excision was done in four patients and in another four a mastectomy. In the non-MRI group, 19/180 (10.6%) additional surgical procedures were performed after WLE (P = 0.06). Ten reexcisions were done and nine mastectomies. In 11 of the 22 women in the MRI group and in 13 of the 35 in the non-MRI group incomplete surgery was followed by a higher boost dose at radiotherapy to treat the incompletely excised component rather than additional surgery (Table 4) .
Multivariate results
At multivariate analysis, no factors were associated with incomplete tumor excision in the overall patient cohort. At subset analysis, significant association was found only between absence of MRI and incompletely excised IDC (P = 0.02) ( Table 3 ). The hazard ratio was 0.18 (CI: 0.04-0.81), suggesting that these patients were at a relatively lower risk of incomplete excision of IDC when a preoperative MRI was performed. None of the other co-variates (age, palpability, lymph node status, tumor size, and grade) were significantly associated with incomplete surgical excision, and no factors were found to be associated with presence of ILC or a DCIS component on the excision boundary.
Discussion
We reported our experiences with a clinical guideline established to manage additional findings at preoperative contrast-enhanced MRI of the breast. The impact of this guideline was assessed on the precision of BCT in a retrospective cohort of 349 women treated in the same time period. A total of 173 women underwent preoperative MRI. In the entire cohort no significant difference in incomplete excision between the MRI and the non-MRI group was found (P = 0.17). Further stratification by subset analysis showed significant association between preoperative MRI and reduced rates of incompletely excised infiltrating ductal carcinoma (IDC) (P = 0.02). These findings may provide input to future studies investigating the potential benefit of preoperative MRI in subgroups of patients.
MRI led to treatment change in 11% of patients after pathology proof of malignancy The rate of therapy changes due to benign findings were small (one change to larger wide local excision for a benign finding); no changes to mastectomy were caused by benign findings. MRI also detected contra-lateral cancer occult at conventional imaging in 1.7% of the patients.
The impact of preoperative MRI appeared twofold. Firstly women with more extensive pathology-proven disease were filtered away from the standard BCT eligibility and thus received a more extensive surgical treatment (mastectomy or a wider excision). The increased mastectomy rate in the MRI group raises the concern that MRI leads to over-treatment. Indeed, increased mastectomy rates were also reported in other studies [12, 13, 16] . It is likely that additional malignant disease also occurred in the non-MRI group. This assumption is supported by studies that reported more extensive disease in diverse groups of breast tumors [7, [32] [33] [34] [35] . Consequently, a considerable part of undetected multi-focal tumor may be controlled by adjuvant treatment such as radiotherapy. Nonetheless, it is also known that radiotherapy is ineffective to eradicate large residual tumor burden [2] [3] [4] . It remains to be proven whether conversion of therapy to mastectomy on the basis of additional MRI-detected disease has impact on the 15-20-year local recurrence rates after BCT [18-21, 22, 36-38] . This may be of particular concern in younger patients where the local recurrence rate is approximately twice as large as in older patients. In a retrospective analysis, Fisher and colleagues reported that preoperative MRI reduced the incidence of local recurrence [36] . Impact of preoperative MRI on surgical precision was not addressed. Solin and colleagues reported that the use of MRI in the staging of the patients was not associated with an improvement in local control after BCT [37] . One of the study limitations, indicated by the authors, was a significantly lower age of women in the MRI group, which makes differences in local recurrence difficult to interpret. In contrast to Fisher et al., Solin and colleagues took differences in age and adjuvant treatment into account in their analysis. Local recurrence was not an end-point of our current study. A second impact of MRI appears to be the high accuracy at which the extent and location of IDC is visualized. This provided the surgeons with a better preoperative assessment resulting in reduced rates of incompletely excised IDC. Despite observations from other studies demonstrating superior sensitivity of MRI for ILC compared to that of conventional breast imaging [39] [40] [41] [42] [43] [44] , we were unable to translate these findings to reduced rates of incompletely excised ILC. Several explanations may exist. First, the number of patients with ILC was relatively small in our cohort. Secondly, all patients in our study were eligible for BCT on the basis of conventional imaging thus excluding tumors larger than 3 cm that were also included in other studies. Thirdly, evidence of multi-focal disease elsewhere in the breast may be difficult to extract from the cut margins of the WLE specimens at histopathology due to the finite tissue sampling and the typically diffuse multi-nodular pattern of growth of ILC [45, 46] . Some of these considerations also hold for DCIS. Moreover, variable sensitivity of MRI for the detection of pure DCIS has been observed in other studies [10, [47] [48] [49] [50] .
Study design
A randomized clinical trial (RCT) is the standard study design to provide level-I evidence for medical intervention studies. Level-II evidence is available showing that breast MRI visualizes disease extent more accurately than conventional breast imaging [8] [9] [10] [11] . This evidence has created much confidence in favor of MRI in patients as well as in practitioners, making it difficult to implement prospective comparative level-I studies. To our knowledge, there are currently only two RCTs that address aspects discussed in the present study. The first one is the COMICE (comparative effectiveness of magnetic resonance imaging in breast cancer) trial [38] , investigating the role of the MRI in the preoperative staging of breast cancer. The second one is the MONET (MR mammography Of Nonpalpable BrEast Tumors) trial [51] , evaluating whether MRI will improve breast cancer management for non-palpable tumors. Neither trials have been designed specifically to answer the question whether MRI will reduce local recurrence after long-term follow-up. Moreover, potential differences in how MRI findings are incorporated into clinical decision-making may lead to differences in outcome and cost-benefit between hospitals.
The design and results of the present study may be useful in follow-up studies to examine differences in local recurrence between ''MRI-proven unifocal'' breast tumors and tumors where only conventional imaging was performed. Studies concerning the cost effectiveness of MRI and the selection of patients for partial breast irradiation (PBI) may also benefit from these findings.
Study limitations
An obvious drawback of non-randomized studies is that they are prone to diverse bias and confounders. The women in the current study were not randomized, but consecutively recruited for a preoperative MRI scan. They were treated in the same time period as the patients in the non-MRI group, were included at similar rates during the investigated study period, under the same circumstances and had the same tumor characteristics. It allowed us to explore the potential impact of our preoperative guidelines on the management of additional MRI findings.
Although there was no selection on age in the current study we did observe a lower mean age in the MRI group, comparable to the observations of Solin et al. [37] . We analyzed the allocation procedure but could not find an explanation for this finding. It is likely that older women refused more often to undergo preoperative MRI. The multivariate analysis was performed taking the differences in age into account. Premenopausal women are at increased risk of local recurrence because of dense breast tissue (resulting in difficulty to visualize tumor extent) and increased tumor aggressiveness [3] [4] [5] . Nonetheless, despite the younger age of the women in the MRI group, this group still showed more complete excisions of IDC than the non-MRI group. This effect was not caused by larger excision volumes in the MRI group compared to the non-MRI group.
Conclusions
Preoperative MRI did not significantly affect the overall rate of incomplete tumor excision, but it yielded significantly lower rate of incompletely excised IDC. Preoperative MRI detected disease with larger extent in 11% of all patients eligible for BCT on the basis of conventional imaging and palpation, thus leading to a-prior changes in treatment.
